Zhejiang Jiuzhou Pharmaceutical Co., Ltd (SHA:603456)

China flag China · Delayed Price · Currency is CNY
13.96
-0.19 (-1.34%)
Apr 29, 2026, 3:00 PM CST
0.72%
Market Cap 12.48B
Revenue (ttm) 5.22B
Net Income (ttm) 651.95M
Shares Out 881.71M
EPS (ttm) 0.73
PE Ratio 19.39
Forward PE 12.32
Dividend 0.30 (2.12%)
Ex-Dividend Date Sep 8, 2025
Volume 20,152,442
Average Volume 18,058,617
Open 14.01
Previous Close 14.15
Day's Range 13.86 - 14.09
52-Week Range 13.66 - 22.25
Beta 0.30
RSI 25.44
Earnings Date Apr 24, 2026

About SHA:603456

Zhejiang Jiuzhou Pharmaceutical Co., Ltd operates as contract development and manufacturing organization (CDMO) company in China and internationally. The company offers small molecule, drug product, and peptide CDMO services. It also involved in business related to supporting the development of new drugs and pharmaceuticals. It serves global pharmaceutical companies, biotechnology companies, and scientific research institutions. Zhejiang Jiuzhou Pharmaceutical Co., Ltd was founded in 1973 and is headquartered in Taizhou, China. [Read more]

Sector Healthcare
Founded 1973
Employees 5,001
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603456
Full Company Profile

Financial Performance

In 2025, SHA:603456's revenue was 5.51 billion, an increase of 6.74% compared to the previous year's 5.16 billion. Earnings were 730.07 million, an increase of 20.46%.

Financial Statements

News

There is no news available yet.